通化东宝：公司有胰岛素周制剂相关布局，目前处于临床前研究阶段

Core Viewpoint - The company is currently engaged in the development of insulin depot formulations and is in the preclinical research stage for its fourth-generation insulin products [1] Group 1 - The company has received inquiries from investors regarding its plans for fourth-generation insulin depot formulations [1] - The company confirmed that it has relevant research and development activities in insulin depot formulations [1] - Future research and development progress will be disclosed in accordance with relevant regulations and requirements [1]